Gastrointestinal stromal tumors (GISTs) are the most common nonepithelial neoplasm of the gastrointestinal tract and show a predilection for the stomach. Most are detected because of symptoms, but some are incidental findings at autopsy or surgery for other reasons. Incidental GISTs tend to be smaller at diagnosis, but even small (<1 cm) GISTs have been shown to harbor activating KIT mutations at rates similar to advanced GISTs. However, the prevalence and characteristics of small GISTs in surgical resections of the esophagogastric junction (EGJ) remains unclear. We studied 150 esophagogastric resections for esophageal or EGJ carcinomas (100 with preoperative chemoradiation and 50 untreated cases) that had been extensively embedded for histologic examination (mean 30 sections/case). Number, size, morphology, and location of all GISTs and leiomyomas were recorded. All potential GISTs were evaluated with CD117 and CD34 immunohistochemistry, and a subset (35) leiomyomas with smooth muscle actin, desmin, and CD117. We found 18 incidental GISTs in 15 of 150 (10%) patients; 3 patients harbored 2 separate lesions. Prevalence of GIST was identical in treated (10 of 100) and untreated (5 of 50) cases. All (100%) showed positivity for both CD117 and CD34 and all were of spindle cell morphology. Lesions ranged from 0.2 to 3.0 mm in size (mean 1.3 mm). Eight (44%) were based in the outer muscularis propria, 7 (39%) in inner muscularis, and 3 (17%) between the muscle layers. The lesions tended to cluster near the EGJ, with 8 (44%) on the gastric side, 9 (50%) on the esophageal side, and 1 (6%) undetermined owing to overlying ulceration. Leiomyomas were even more common than GIST, occurring in 47% of patients (44% of treated and 52% of untreated, P = 0.39), with a mean of 3 leiomyomas per patient (range 1 to 13) and mean size of 1.7 mm (range 0.2 to 12 mm). Unlike colorectal leiomyomas, most (91%) EGJ leiomyomas were located in the inner muscularis propria and only rarely (1%) in muscularis mucosa. These results suggest that GIST and leiomyoma are common incidental ''seedling'' lesions of the EGJ, found in 10% and 47% of patients undergoing surgery for esophageal carcinoma. The common occurrence of microscopic GISTs compared with the rarity of clinically manifest and malignant esophagogastric GISTs suggests that additional genetic or epigenetic alterations must happen for neoplastic progression.
M esenchymal tumors of the gastrointestinal tract are less frequent than epithelial neoplasms but they are by no means rare. Gastrointestinal stromal tumors (GISTs) represent the most common mesenchymal tumor of the tubular gastrointestinal tract and can be defined as cellular spindled, epithelioid, or pleomorphic lesions that almost uniformly express KIT (CD117) protein. 16 Most GISTs arise in the stomach (50% to 70%), followed by small intestine (25% to 35%) and colorectum (5% to 10%). 12, 14, 16, 19, 20 Esophageal GISTs are rare lesionsoverall comprising r2% of GISTs 16 -and many descriptions of esophageal GISTs are individual case reports. 4, 7, 10 In 2 large series of 288 GISTs from Sweden 19 and 136 GISTs from Hungary, 20 there were no esophageal GISTs represented. Despite their rarity, esophageal GISTs are morphologically and immunophenotypically similar to those occurring in other regions of the gastrointestinal tract. The most coexpress CD117 and CD34 proteins, perhaps at an even higher rate than those in the stomach and small intestine. 4, 7, 10, 15 Furthermore, they harbor activating c-kit gene mutations similar to extraesophageal GISTs; 5 of 10 esophageal GISTs ranging from 6 to 17 cm had deletions in exon 11 in a study by Miettinen and colleagues, 15 and an in-frame 6-base pair deletion in exon 11 of c-kit was found in a 5.3 cm esophageal GIST reported by Iijima et al. 10 In contrast to GISTs, true leiomyomas of the muscularis propria are common in the esophagus and rare in the gastric body and antrum. Leiomyomas are the most frequent mesenchymal tumor of the esophagus, where they outnumber GIST by a ratio of approximately 3 to 1. 15 Both GISTs and leiomyomas are usually detected because of clinical symptoms that range from gastrointestinal bleeding 12, 17, 18, 20, 24 to abdominal pain, 11, 17, 18, 24 dysphagia, 4, 10, 15, 18 and palpable abdominal masses. 12, 20, 24 However, incidentally detected GISTs 6, 11, 15, 17, 19, 20, [23] [24] [25] and leiomyomas 18, 26 of the upper gastrointestinal tract are increasingly recognized at autopsy or during surgical procedures for other reasons; not surprisingly, these incidental lesions are usually smaller than their symptomatic counterparts. 6, 18, 23, 26 In 1981, Takubo et al 26 coined the term ''seedling'' leiomyomas to describe small ( <7 mm) esophageal leiomyomas found incidentally during surgery or at autopsy, because of their resemblance to millet seeds. Among 342 patients, nearly 8% had leiomyomas, most of which clustered around the region of the esophagogastric junction (EGJ). An even higher frequency of leiomyomas (22%) was reported recently by Agaimy and Wunsch 2 in a study of 77 patients undergoing surgical resections for distal esophageal carcinomas. The authors of that study also described a high rate (9.1%) of what they termed ''interstitial cell of Cajal (ICC) hyperplasias'' that were immunophenotypically similar to minute GISTs.
In this study, we evaluate the prevalence and morphologic characteristics of incidentally discovered leiomyomas and GISTs in a large series of extensively embedded specimens from the esophagogastric region. Our data suggest that both types of seedling mesenchymal lesions are common among patients with esophageal carcinomas, despite their lack of clinical recognition, and could potentially represent the earliest recognizable precursors to clinically symptomatic tumors.
MATERIALS AND METHODS

Study Population
The study population consisted of 2 groups of randomly selected patients who underwent esophagectomy at The University of Texas M. D. Anderson Cancer Center (MDACC, Houston, TX). The first group included 100 patients who had received preoperative chemoradiation followed by esophagectomy for clinical stage II, stage III, or stage IVA carcinomas of the EGJ or distal esophagus between the years 2000 and 2005. Almost all (96 patients, 1 with mixed adenocarcinoma/ neuroendocrine carcinoma) had adenocarcinoma of the distal esophagus or EGJ; there were only 4 squamous carcinomas. To determine whether preoperative therapy had any effect on the presence or number of GIST/leiomyomas, we included a second group of 50 patients who received esophagectomy without preoperative chemoradiation between the years 1991 and 2005 for superficial Barrett neoplasias, including 12 cases of high-grade dysplasia, 11 cases of T1a adenocarcinoma, 24 cases of T1b adenocarcinoma, and 3 cases of T1c adenocarcinoma. As previously described, 13 T1a carcinoma was defined as invasion into lamina propria, T1b as invasion into muscularis mucosae, and T1c as invasion into superficial submucosa. The study was approved by the MDACC institutional review board.
Histologic and Immunohistochemical Evaluation
All specimens had been either entirely or extensively embedded to include the EGJ region and distal esophagus; the extensive embedding had been performed to evaluate for residual carcinoma rather than for evaluation of mesenchymal lesions. We retrospectively reviewed the hematoxylin and eosin-stained sections, looking for mesenchymal lesions that were morphologically suspicious for GIST based on nodular growth and cellularity, regardless of size. All lesions suspicious for GIST were then subjected to immunohistochemistry with antibodies directed against CD117 (1:1000 dilution, Dako, polyclonal; steam/EDTA pretreatment) and CD34 (1:100 dilution, Becton-Dickinson, clone MY10; steam/EDTA pretreatment). In 2 separate cases, smooth muscle actin (SMA) immunostaining (1:50 dilution, Dako, clone 1A4; no pretreatment) had also been performed. For the purpose of this study, we defined GISTs as lesions with characteristic GIST morphology 16 that were positive for CD117.
We also recorded the number of small, seedling leiomyomas within muscularis propria or mucosae; leiomyomas were defined morphologically as nodular, circumscribed proliferations of plump eosinophilic cells that were histologically similar to the surrounding smooth muscle cells, but with a more disorganized, ''whorled'' appearance. Because leiomyomas are morphologically characteristic and lack the cellularity of GISTs, we performed immunohistochemistry for CD117, SMA, and desmin (1:100 dilution, Dako, clone DER11; protease pretreatment) on only a subset (35) of these lesions. Six additional leiomyomas had been previously stained at the time of original sign-out for SMA, CD34, and c-kit.
For both leiomyomas and GISTs, we recorded the number, size, location relative to the EGJ (esophagus or stomach), and location within the muscular wall (outer circular muscle, inner circular muscle, or muscularis mucosae). In GISTs, the morphology (spindled, epithelioid, or other) was also noted.
RESULTS
Clinical Characteristics
Among the 100 patients with preoperative chemoradiation, there were 91 men and 9 women with a mean age of 59.7 years (range, 23 to 79 y). The number of histologic sections containing muscular wall ranged from 8 to 74, with a mean of 31.3 per case. Among the 50 control patients who had not received preoperative therapy, there were 45 men (90%) and 5 women (10%) with a mean age of 61.7 years (range 38 to 80 y). Number of histologic sections containing muscle ranged from 7 to 74, with a mean of 28.5 per case. There was no statistically significant difference in any of these parameters between the 2 groups.
GISTs
Eighteen confirmed GISTs (positive CD117 immunostaining) were present in 15 (10%) of the total 150 patients among the 2 study groups. There were 12 patients with one GIST each and 3 patients with 2 separate GISTs. Additionally, there were 5 lesions that were morphologically identical to GISTs but which we were unable to confirm immunohistochemically because they were no longer present on the recut sections (in 1 case, the lesion was present on the slide stained for CD34 and this was strongly positive). If these lesions had been confirmed by positive CD117 staining, there would have been a total of 23 GISTs among 18 (12%) patients, with 1 GIST in 14 patients, 2 GISTs in 3 patients, and 3 GISTs in 1 patient. The data presented below and in Table 1 reflect only those lesions that were confirmed by CD117 staining.
There was a tendency toward increased age (mean, 64.5 y; range, 53 to 77 y) and male sex (15 men:0 women) among the patients with GISTs as compared with patients without GISTs (mean age, 59.9 y; 121 men:14 women), but neither trend reached statistical significance (P = 0.09 for age and 0.36 for sex). Preoperative chemoradiation did not seem to have any effect on the prevalence or number of GISTs identified at esophagectomy. In the 50 untreated cases, there were 6 GISTs among 5 (10%) patients, whereas in the 100 treated cases there were 12 GISTs among 10 (10%) patients.
Size of the lesions ranged from 0.2 to 3 mm with a mean diameter of 1.3 mm. In only 1 case was the GIST identified by the surgeon at the time of esophagectomy (a small subserosal gastric nodule that was submitted separately for histologic evaluation); in all of the remaining cases, the lesions were incidental histologic findings. Morphologically, all demonstrated an exclusively spindle cell pattern ( Fig. 1 ) without significant nuclear pleomorphism; one had calcification. Eight (44%) were located on the gastric side of the EGJ and 9 (50%) on the esophageal side; in 1 case, an exact location could not be determined because of extensive overlying ulceration. In 8 (44%) cases, there was predominant growth into the inner circular muscle and in 7 (39%) cases into the outer circular muscle. The remaining 3 (17%) cases showed nodular growth limited to Auerbach plexus between the muscle layers. We did not observe any specific geographic relationship between location of (residual) carcinoma and location of GISTs; none of the GISTs was directly infiltrated by tumor. By definition, all GISTs were CD117 positive, with strong and diffuse labeling in 17 cases and focal in 1 case. CD34 was positive in all 18 GISTs, again with strong and diffuse labeling in 17 cases and focal staining in 1 case. Immunohistochemistry for SMA performed in 2 cases was negative ( Fig. 2 ).
Leiomyomas
Minute leiomyomas were very frequently observed with a total of 209 lesions in 70 of 150 (46.7%) patients (61 men:9 women). The number of leiomyomas ranged from 1 to 13 (with a mean of 3 per case) and were multiple in 47 patients (67.1%) ( Fig. 3 ). There was a small but statistically significant increase in the age of patients with leiomyomas (mean, 63.2 y; range, 37 to 80 y) as compared with those without leiomyomas (mean, 59.3 y; range, 23 to 79 y; 2-tailed P = 0.02). There was no significant difference in sex distribution between the 2 groups (P = 0.26). We also evaluated whether the prevalence of leiomyoma might reflect the number of histologic sections evaluated. Among patients with leiomyomas, a mean of 32.1 muscle-containing sections/case were available, compared with only 28.8 sections/case in the group without leiomyomas, but this difference did not reach statistical significance (P = 0.12).
Patients who had not received preoperative chemoradiation were more likely to have leiomyomas detected at esophagectomy (26 of 50, 52%) than patients who had undergone preoperative therapy (44 of 100, 44%). This small difference was not statistically significant (P = 0.39), and could potentially reflect the greater degree of muscle destruction that was observed in the treated cases. Leiomyomas ranged in size from 0.2 to 12 mm, with a mean diameter of 1.7 mm. Of 41 lesions subjected to immunohistochemistry for SMA and CD117, all were strongly and diffusely positive for SMA ( Fig. 4) and negative for CD117. Immunostaining for desmin was performed on 35 cases and was diffusely positive in 34 (the remaining lesion was not represented on the deeper cut). Leiomyomas arose most commonly (191 cases, 91%) in the inner circular muscle (Fig. 4 ). Only 9 (4%) were found in the outer circular muscle, and 2 (1%) in the muscularis mucosae. Location of the remaining 7 leiomyomas could not be determined because of unclear orientation of the sections, with stripping of the overlying mucosa. Most (116 cases, 56%) were present on the gastric side of the EGJ, 80 (38%) were on the esophageal side, and 13 (6%) were indeterminate owing to extensive mucosal ulceration. For the esophageal leiomyomas, exact determination of distance from the EGJ was not possible in most cases but all lesions were located within smooth muscle supporting origin in the distal third of the esophagus.
DISCUSSION
GISTs exhibit morphologic and immunophenotypic differentiation along the lines of ICCs. Like ICCs, they are classically vimentin+, CD34 + , CD117 + lesions and arise within the muscularis propria or within the region of Auerbach plexus where normal networks of ICCs exist. However, specific precursor lesions of GISTs have not been well defined, nor has a specific size criterion for GIST been established. In the largest published study of 1765 gastric GISTs, 17 the smallest lesion was 3 mm, but smaller or even microscopic lesions defined as GISTs have also been reported, particularly in some patients who have a genetic predisposition toward GIST formation. Walsh and Bodurtha 27 described a 56-year-old man with neurofibromatosis type 1 (NF1) who was incidentally found to have 2-minute jejunal GISTs at the time of resection for a clinically apparent 5-cm GIST, which had caused biliary obstruction. One of the smaller lesions measured 5 mm; the size of the second GIST was not stated but the accompanying photomicrograph showed a nodular lesion of <1 mm within Auerbach plexus. In a detailed study of 15 patients with NF1 (11 of whom had multiple GISTs ranging from 3 to over 100 tumors), macroscopic tumors of the small bowel were as small as 1 mm, and in 7 patients the tumors were incidental findings. 3 That same study describes a 70-mm GIST within the esophageal wall. 3 Finally, Perez-Atayde et al 21 reported numerous macroscopically detected GISTs as small as 2 mm within the stomach and duodenum of a 16-year-old girl with the Carney triad. The authors further described what they termed ''nests of in situ tumor'' and ''tumorlets'' within (and overrunning) the duodenal myenteric ganglia that were hypothesized to represent GIST precursors. 21 Reported in 1993, neither CD34 nor CD117 immunostaining results of these minute GISTs and tumorlets was available.
The results of our present study, demonstrating minute GISTs in 10% of esophagectomy specimens in patients with Barrett dysplasia or esophageal carcinoma, indicate that incidental GISTs are much more common than large, clinically significant GISTs. A recent Swedish study estimated the prevalence of all GISTs at only 129 per million and the annual incidence at 14.5 per million, the majority of which (69%) were symptomatic and clinically detected. 19 In contrast, a much higher prevalence of incidental GIST was recently suggested in a study of 517 patients undergoing laparoscopic Roux-en-Y gastric bypass surgery for obesity, 4 (0.8%) of whom had small GISTs (4, 5, 7, and 8 mm) protruding from the serosal surface of the upper stomach. 23 As these were all FIGURE 4 . A, Seedling leiomyomas of the esophagus with nodular contours and plump, eosinophilic cells similar to those of the surrounding muscularis propria. In this field, there are 2 leiomyomas within the inner circular muscle. B, Strong reactivity for SMA in both the leiomyomatous nodules and muscularis.
Am J Surg Pathol Volume 31, Number 11, November 2007 ''Seedling'' Mesenchymal Tumors macroscopically visible lesions to the surgeon, it is likely that an even higher prevalence of microscopic GISTs would have been found had there been systematic histologic evaluation. In our population of 18 immunohistochemically confirmed GISTs among 150 surgical patients, only 1 lesion (a 3-mm GIST on the gastric serosal surface) was noted at the time of operation; the others were incidental histologic findings with an even smaller mean diameter of 1.3 mm. It is possible that the confounding presence of radiation-induced fibrosis or intramural tumor masses in many of the patients could have interfered with gross recognition of small GISTs, but the minute size of many lesions (as small as 0.2 mm) suggests that the majority will only be detected because of extensive histologic sectioning and routine histologic evaluation. The 10% prevalence of incidental GISTs in this study closely matches the 9.1% prevalence of ''ICC hyperplasias'' reported recently by Agaimy and Wunsch 2 among a group of 77 patients undergoing esophagectomy for adenocarcinomas, squamous carcinomas, or neuroendocrine carcinomas. This is despite the more extensive histologic sectioning in our patients (mean of 30 sections vs. 8 sections per case). This could potentially reflect the tendency of microscopic GISTs to cluster near the GEJ so that additional sections of mid esophagus or gastric margins, for example, would yield diminishing numbers of lesions. There has been no other prospective, histologic evaluation for GISTs in patients who do not have a genetic predisposition for stromal tumors (eg, NF1, Carney's triad, or germline c-kit mutations).
Agaimy's study did not define microscopic lesions as GISTs but instead as either circumscribed or noncircumscribed ICC hyperplasias. As evidence, it cited a previous study using X-chromosome inactivation patterns to evaluate the monoclonal or polyclonal nature of ICC proliferations in patients with familial GISTs. 5 The authors of that study defined proliferations of CD34 + , CD117 + spindled cells as ''diffuse ICC proliferations'' when <3 mm and as GISTs when >5 mm, based in part on the apparent polyclonal nature of the small ICC proliferations in 2 females with germline c-kit gene mutations. However, morphologically the diffuse ICC proliferation illustrated by the authors was distinct from the lesions that we have termed seedling or microscopic GISTs in our study, appearing more as a bandlike or diffuse spindle cell growth between the inner and outer circular muscle layers. 5 This diffuse, bandlike proliferation CD34 + , c-kit+ spindle cells within myenteric plexus was also described in reports of familial GIST 8 and familial gastrointestinal autonomic nerve tumors 9 due to activating germline c-kit mutations. The ICC proliferations in those reports lacked the distinct nodularity seen in our patients; additionally, none of our cases showed diffuse proliferation of ICCs, either by hematoxylin and eosin or by immunohistochemistry.
We do not believe that there is any clear demarcation between ''true'' GIST and their small morphologic counterparts that we have termed seedling GISTs in the present study. It is clear that small GISTs have an almost uniformly benign biologic behavior; in Miettinen's large series of gastric GISTs, there was no tumor-specific mortality among 116 patients with lesions r2 cm. 17 Yet even small GISTs have been shown to harbor activating KIT gene mutations similar to those in larger GISTs. Corless et al 6 studied 13 morphologically benign GISTs ranging from 4 to 10 mm, all of which were incidental findings at surgery, endoscopy, or autopsy, and documented KIT mutations in 11 (85%),including a 4-mm lesion. Both the frequency of KIT mutations and their distribution (10 with mutations in exon 11 and 1 with an exon 9 mutation) were nearly identical to previous findings in advanced or metastatic GISTs. 6 This suggested that KIT mutations serve as ''gatekeeper'' alterations that play a fundamental role in early GIST development. Similar to the minute colorectal adenomas that arise because of loss of the gatekeeper function of the adenomatous polyposis coli (APC) gene, we hypothesize that the seedling GISTs reported in the current study, and some of the circumscribed ICC hyperplasias reported by Agaimy, represent the earliest morphologically recognizable GISTs.
It is not clear from our study whether the 10% prevalence of seedling GISTs in the esophagogastric region is influenced by the presence of epithelial neoplasias or whether a similar frequency of GISTs would be found in the general population. Our data indicate that preoperative chemoradiation itself had no influence, as there was no difference between the numbers of GISTs in treated patients (12 lesions in 100 cases) and untreated patients (6 lesions in 50 cases). In fact, the other mesenchymal lesion in this study, seedling leiomyomas, were slightly more common in untreated patients, although this might reflect destruction of the muscular wall and therefore some small leiomyomas by preoperative chemoradiation. Additionally, stage of the overlying carcinoma clearly did not influence the prevalence of GIST, as the untreated cases included only T0 or T1 carcinomas, whereas the treated cases were clinically stage II, III, or IVA. Among the 50 untreated cases, 2 of the 5 patients with GISTs had only high-grade dysplasia in Barrett esophagus and lacked invasive carcinoma. The rate of GIST associated with high-grade dysplasia (2 of 12, 17%) does not differ significantly from the rate of GIST in invasive carcinomas (P = 0.34), suggesting that invasion per se does not promote the growth of GISTs.
Many small, histologically benign GISTs are found incidentally during surgery for other neoplasms (including neoplasms remote from the site the GIST 22 ), but it remains unclear whether this is coincidental occurrence or an etiologic association. 1 In Agaimy's study, only one small (2 mm) fundic GIST was present in a control group of 32 autopsy EGJ specimens from patients without esophageal or gastric carcinomas, suggesting to the authors that the rate of seedling esophagogastric GISTs was lower in the general population than in the cancer population. However, this was not a statistically significant difference (P = 0.43), and there has been no other study evaluating the prevalence of seedling GISTs in the noncancer population.
Agaimy's study also found a lower frequency of leiomyomas in their control group (2 of 32, 6%) than in their cancer group (17 of 77, 22%), a difference of borderline statistical significance (P = 0.055). Agaimy's rate of leiomyomas was significantly higher than the 7.9% prevalence reported in 1981 by Takubo et al, 26 the only prior study to systematically evaluate for seedling leiomyomas of the EGJ. We found an even higher frequency (overall 47%) of seedling leiomyomas in our population of 150 patients with carcinoma or Barrett dysplasia, potentially a reflection of the higher number of histologic sections examined per case. However, the characteristics of seedling leiomyomas-their close association (91%) with the inner muscularis propria, their tendency to cluster near the EGJ, and their frequent multiplicity (67%)-are all similar to prior reports.
In summary, we have shown high rates of incidental, seedling GISTs, and leiomyomas near the EGJ in a large series of patients undergoing surgical resections for esophageal carcinoma or Barrett dysplasia. We hypothesize that these seedling lesions represent the earliest morphologically recognizable GISTs and leiomyomas, as their morphology and immunophenotype are identical to their larger counterparts. Whether the prevalence of these lesions is as high in the general population will require further investigations.
